<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Covance News</title>
<description>Covance is a comprehensive, biopharmaceutical drug development services company with preclinical and clinical research operations across the globe.</description>
<language>en-us</language>
<copyright>Copyright 2010 Covance Inc. All rights reserved.</copyright>
<category>CRO for Drug Development Services</category>
<image>
<title>Covance News</title>

<url>http://www.covance.com/images/img_gfx/covance.gif</url>
<width>175</width>
<height>37</height>
<link>http://www.covance.com/</link>
</image>

<item>
<title><![CDATA[View Our 2012 Annual Report and 2013 Proxy Statement]]></title>
<link><![CDATA[http://www.covance.com/investors/investor-info/]]></link>
<description>View Our 2012 Annual Report and 2013 Proxy Statement</description>
<pubDate>Mon, 25 Mar 2013 16:00:00 EDT</pubDate>
</item>
<item>
<title><![CDATA[American Association of Pharmaceutical Scientists - National Biotechnology Conference]]></title>
<link><![CDATA[http://www.aaps.org/nationalbiotech]]></link>
<description>American Association of Pharmaceutical Scientists - National Biotechnology Conference</description>
<pubDate>Mon, 20 May 2013 11:46:26 EDT</pubDate>
</item>
<item>
<title><![CDATA[Covance Testing Method Named Industry Standard ]]></title>
<link><![CDATA[http://www.covance.com/investors/financial-info/press-releases/press-release.php?reqtype=releasetxt&reqid=1822908]]></link>
<description>Covance Testing Method Named Industry Standard </description>
<pubDate>Tue, 21 May 2013 15:19:18 EDT</pubDate>
</item>

</channel>
</rss>